NUCLEAR MEDICINE PET/CT THYROID CANCER ASSESSMENT, PROTOCOLS, AND INTERPRETATION
Tracking # 20-810197
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
THYROID CANCER IS OFTEN DESCRIBED AS AN INDOLENT PATHOLOGY WITH A GOOD PROGNOSIS; HOWEVER, POORLY DIFFERENTIATED SUBTYPES DESCRIBE AN AGGRESSIVE BEHAVIOR WITH EXTENSIVE METASTATIC DISEASE AT THE TIME OF DIAGNOSIS. PET/CT HAS BEEN ESTABLISHED AS AN IMPORTANT MODALITY IN THE DETECTION OF POORLY DIFFERENTIATED THYROID CANCER. THIS ACTIVITY REVIEWS THE BIOCHEMICAL BASIS, INDICATIONS, TECHNIQUE, AND CLINICAL SIGNIFICANCE OF PET/CT, HIGHLIGHTING THE INTERPROFESSIONAL TEAM'S ROLE IN EVALUATING AND TREATING PATIENTS WITH THYROID CANCER.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1h
AMA Category I
Physician Assistant
1h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1h
AMA Category I